Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.

Abstract

Rofecoxib treatment increased physical and mental HRQL domain scores on the SF-36. Improvements in mental health with rofecoxib use primarily resulted from effective treatment of OA (i.e., reduction in pain and improvement in physical function).